| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228772A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228771A 1,3-diheterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228767A Bidentate metalloprotease inhibitors |
| 09/15/1999 | CN1228707A Titanium slow-release composition |
| 09/15/1999 | CN1228705A Use of oligosaccharide as immunomodulator in dermato-cosmetic composition |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228311A Drug for curing psoriasis |
| 09/15/1999 | CN1228300A Method for preparing freckle-removing pretty gel cosmetics |
| 09/15/1999 | CN1228254A Alcohol based anti-microbial compositions with cosmetic apparatus |
| 09/15/1999 | CN1045088C Purine and guanine compounds as inhibitors of PNP |
| 09/14/1999 | US5952510 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952373 Applying to the skin an effective amount of one or more flavonoids |
| 09/14/1999 | US5952011 Human placental transglutaminase polypeptide and nucleotide sequences encoding it, or an allelic variant thereof; use as wound-healing agent |
| 09/14/1999 | US5952001 Preparing pharmaceutical, dermatological or cosmetic preparations for the prevention or treatment of allergic manifestations such as skin allergy, bronchial asthma, or inflammation, or as free radical scavengers |
| 09/14/1999 | US5951990 Ascorbyl-phosphoryl-cholesterol |
| 09/14/1999 | US5951982 Administering an antibody thaat binds an epitope of vcd44; antitumor,-metastasis and carciogenic agents |
| 09/14/1999 | CA2174598C Use of an inhibitor of an hmg-coenzyme-a reductase to prevent aging of the skin or to stimulate the process of epidermal renewal |
| 09/14/1999 | CA2144125C Use of sulfonic acids as antiageing agents in a cosmetic or dermatologic composition |
| 09/10/1999 | WO1999045027A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045009A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 09/10/1999 | WO1999044989A1 Matrix metalloproteinase inhibitors |
| 09/10/1999 | WO1999044643A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 09/10/1999 | WO1999044631A1 Topical composition containing human epidermal growth factor |
| 09/10/1999 | WO1999044629A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | WO1999044622A1 Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 09/10/1999 | WO1999044617A1 Activated vitamin d3 emulsion-type lotions |
| 09/10/1999 | WO1999044602A1 Inflammatory cell inhibitors |
| 09/10/1999 | WO1999044586A1 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect |
| 09/10/1999 | WO1999044585A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 09/10/1999 | WO1999044582A2 Nontoxic vernix compositions and method of producing |
| 09/10/1999 | WO1999044578A1 Formulations with an anti-viral effect |
| 09/10/1999 | WO1999032514A3 Sag: sensitive to apoptosis gene |
| 09/10/1999 | WO1999032099A3 Use of fucane for regulating the reconstruction of connective tissues |
| 09/10/1999 | WO1999025819A3 Antisense oligonucleotides against tenascin for treating vitiligo |
| 09/10/1999 | CA2323731A1 Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect |
| 09/10/1999 | CA2322850A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 09/10/1999 | CA2322838A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | CA2322486A1 Inflammatory cell inhibitors |
| 09/10/1999 | CA2322450A1 Formulations having an antiviral action |
| 09/10/1999 | CA2322199A1 Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 09/10/1999 | CA2321732A1 Nontoxic vernix compositions and method of producing |
| 09/10/1999 | CA2317502A1 Matrix metalloproteinase inhibitors |
| 09/09/1999 | DE19809304A1 Formulierungen mit antiviraler Wirkung Formulations having antiviral activity |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0939829A1 Methods of modulating melanin synthesis |
| 09/08/1999 | EP0939803A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 09/08/1999 | EP0939751A1 Macrophage lipid chemoattractant |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | CN1228083A Arylsulfonylamino hydroxamic acid derivatives |
| 09/08/1999 | CN1228024A Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/08/1999 | CN1227742A Mosquito-repelling skin-care cream without irritation and allergia |
| 09/07/1999 | US5948898 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression |
| 09/07/1999 | US5948823 Irradiation protection method |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948795 Benzothiopene compounds, and uses and formulations thereof |
| 09/07/1999 | US5948777 Cannabinoid receptor agonists |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 09/07/1999 | US5948392 Stable sulfide compositions, uses, and process for preparation thereof |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | WO1999043787A2 A living chimeric skin replacement |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043646A1 Cyclohexanediole derivatives |
| 09/02/1999 | WO1999043426A1 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles |
| 09/02/1999 | WO1999043344A2 Matrix protein compositions for wound healing |
| 09/02/1999 | WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | CA2640994A1 Enamel matrix protein composition for preventing or treating infection |
| 09/02/1999 | CA2324452A1 A living chimeric skin replacement |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/01/1999 | EP0938898A2 Treatment of pruritus |
| 09/01/1999 | EP0938891A1 Cosmetic composition containing cinnamic acid or its derivatives and its use |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938296A1 Method of treating alopecia |
| 09/01/1999 | EP0721348B1 Monoglyceride/lactate ester permeation enhancer |
| 09/01/1999 | EP0701616B1 Multicistronic expression of recombinant genes in bacterial cells |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 09/01/1999 | CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 09/01/1999 | CN1227123A Stain clearing and face beautifying pill |
| 09/01/1999 | CN1227116A Technology for producing comedo eliminating liquid |
| 09/01/1999 | CN1227108A Method for preparing burn plaster |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945441 Administering to promote hair germination |